CREDIT AGREEMENT among ANI PHARMACEUTICALS, INC., as Lead Borrower,Credit Agreement • August 13th, 2024 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 13th, 2024 Company Industry JurisdictionCREDIT AGREEMENT, dated as of August 13, 2024, by and among ANI PHARMACEUTICALS, Inc., a Delaware corporation (the “Lead Borrower”), ANIP ACQUISITION COMPANY, a Delaware corporation (the “Initial Subsidiary Borrower”), the Additional Subsidiary Borrowers (as hereinafter defined), the Guarantors (as hereinafter defined), the Lenders (as hereinafter defined), and JPMORGAN CHASE BANK, N.A., as administrative agent for the Lenders hereunder (in such capacity, the “Administrative Agent”).
AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • November 8th, 2023 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionThis AMENDMENT NO. 1 TO CREDIT AGREEMENT, dated as of July 3, 2023 (this “Amendment”), is made by and among ANI PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), and TRUIST BANK, as Administrative Agent (in such capacity, the “Administrative Agent”). Capitalized terms used but not defined herein have the respective meanings assigned thereto in the Amended Credit Agreement (as defined below).